Rifaximin for the Secondary Prevention of Recurrent Pouchitis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rifaximin for the Secondary Prevention of Recurrent Pouchitis	Crohn ileitis, Digestive System Diseases, Ileal Diseases, digestive system disorder, enteritis, gastroenteritis, intestinal disorder, pouchitis	Recruiting	Phase 4	2026-08-03		NCT06312683

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bausch Health Americas, Inc.	23
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
University of North Carolina, Chapel Hill	249

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
NYU IBD Center	New York	United States	1
University of North Carolina	Chapel Hill	United States	101

Clinical trials